AI is driving an unprecedented wave of innovation in the $6.5 billion healthcare industry — speeding drug discovery, helping doctors diagnose and treat cancer and heart disease, and even predicting the onset of diseases before they happen.
And that’s just for starters.
At our GPU Technology Conference in Washington, D.C., running Nov. 1-2, some of the world’s leading physicians, scientists and researchers discuss the future of AI in healthcare, pharmaceutical and biomedical research.
They’ll join hundreds of other speakers at the two-day event, which also covers such pressing topics as the latest developments in AI for government, cybersecurity, defense and self-driving cars. Washington’s leading AI conference features sessions with congressional leaders, military representatives, university researchers, and speakers from government agencies, including the CIA, DARPA, DOT, NASA and the NIH.
During GTC DC’s dedicated healthcare track, attendees will have a chance to learn about the newest advancements in areas like evidence-based precision medicine, electronic health records for automated diagnoses and AI for medical image analysis.
Wednesday’s keynote on harnessing AI in healthcare will be from Keith Dreyer, vice chairman of radiology and director of the Center for Clinical Data Science at Massachusetts General Hospital, and associate professor of radiology at Harvard Medical School.
Dreyer, who speaks worldwide on the implications of technology on the quality of healthcare, will discuss the importance of defining the role of AI within diagnostic imaging while at the same time ensuring patient safety.
GTC DC’s two healthcare panel discussions will feature some of the foremost experts in medicine, industry and academia on two of the most-discussed topics in medicine today:
- Precision Healthcare – How AI can advance treatment and prevention and examining how researchers must overcome scientific and regulatory hurdles to move research into the marketplace.
- AI in Healthcare: Beyond the Hype Cycle – Sorting hype from reality regarding the true impact of AI on healthcare, including a look at how deep learning is advancing clinical practice.
Nearly 25 talks make up GTC DC’s healthcare track. A few highlights:
- Ronald M. Summers, a senior investigator at the National Institutes of Health, provides an update on deep learning’s impact on radiology, one of the most active areas of research.
- Jayashree Kalpathy-Cramer, a researcher and professor at Harvard Medical School and Massachusetts General Hospital, discusses her automated system for detecting retinopathy of prematurity, a disease that has the potential to blind infants.
- Kyle Fahr, director of data sciences at San Diego-based Illumina, talks about artificial intelligence and the future of genomic medicine.
- John Tenney, director of algorithms at Berkeley Lights, based in Emeryville, Calif., discusses the company’s method of applying neural networks to drug discovery.
The conference will also host hands-on training on some of the technical aspects of using different deep learning frameworks for radiomics, genomics and medical image analysis.
There are a few remaining tickets left for GTC DC, which we’re hosting at the Ronald Reagan Building and International Trade Center in Washington. The show opens Wednesday, so register now.